Towards A Better Paradigm for Head and Neck Cancer Treatment Applying Artificial Intelligence. HNC-TACTIC.

NCT05117775 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2026-05-01

No results posted yet for this study

Summary

This will be an international, multicenter, retrospective, observational, and data-driven study using secondary data captured in EHRs. The extraction of the data captured in the EHRs will be performed with SAVANA's EHRead®, an innovative data-driven system based on Natural Language Processing (NLP) and machine learning. For all patients, the Index Date is defined as the timepoint within the study period when they fulfill ALL inclusion criteria and no exclusion criteria. Follow-up comprises the period between Index Date and the last EHR available within the study period. Additional variable-specific time windows may be considered to optimize data collection.

Conditions

Interventions

OTHER

No intervention - Just description and predictive models

All the groups will be descriptive, there is not intervention, as it is an Observational study applying artificial Intelligence (RWE).

Sponsors & Collaborators

  • Head and Neck Cancer International Group (HNCIG)

    collaborator UNKNOWN
  • Savana Research

    lead NETWORK

Principal Investigators

  • John Almeida · University Health Network and Mount Sinai Hospital

  • Sujith Baliaga · Ohio State University

  • David Casadevall · Medsavana S.L

  • Melvin Chua · National Cancer Centre, Singapore

  • Andreas Dietz · University Hospital of Leipzig

  • Robert Ferris · UPMC Hillman Cancer Center

  • Raul Giglio · Hopital Ángel H. Roffo de Buenos Aires

  • Chris Holsinger · Stanford University

  • Kate Hutcheson · M.D. Anderson Cancer Center

  • Husham Menhanna · Institute of Head and Neck Studies and Education (InHANSE)

  • Pablo Parente · Hospital HM Rosaleda

  • Sandro Porceddu · Queensland Institute of Medical Research (QIMR)

  • Miren Taberna · Medsavana S.L

  • Christian Simon · CHUV Lausanne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-06
Primary Completion
2024-02-28
Completion
2024-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05117775 on ClinicalTrials.gov